Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.

Finasteride slowly binds to 5-alpha-reductase, affecting enzyme stability and inhibitor potency.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Jamogenin from plants may help hair growth and is a potential alternative to finasteride.

Jamogenin and other compounds may help treat hair loss by inhibiting 5-alpha reductase.

Jamogenin and other molecules from plants may help treat hair loss.

Jamogenin and other molecules from plants may help treat hair loss.

Jamogenin and other molecules may help treat hair loss by inhibiting 5-alpha reductase.

Some plant-based products might treat hair loss with fewer side effects than current medications.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.